Premium
EFFICACY AND SAFETY OF ANTI‐PD‐L1 ANTIBODY IN NSCLC PATIENTS WHO PREVIOUSLY TREATED WITH ANTI PD‐1 ANTIBODIES: PRELIMINARY STUDY
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13420_217
Subject(s) - medicine , antibody , oncology , pd l1 , safety profile , pharmacology , immunology , immunotherapy , adverse effect , cancer